A two step model aimed at delivering antisense oligonucleotides in targeted cells

Area of Science:

• Molecular Biology
• Biotechnology
• Drug Delivery

Background:

• Antisense oligonucleotides (ASOs) require efficient cellular uptake for in vivo efficacy.
• Current delivery methods face challenges in targeting specific cells and crossing the cell membrane.

Purpose of the Study:

• To develop and validate a two-step system for enhanced cellular delivery of antisense oligonucleotides.
• To demonstrate the ability of this system to facilitate gene inhibition within targeted cells.

Main Methods:

• Formation of electrostatic complexes between oligonucleotides, a lipopeptide (peptide-ligand model), and a cellular receptor ligand.
• Characterization of peptide-oligonucleotide stoichiometry using a filter elution assay.
• In vitro studies using HeLa cells to assess membrane binding and subsequent intracellular delivery via transfection agents (dendrimers).
• Reporter gene assays to evaluate the functional inhibition mediated by delivered ASOs.

Main Results:

• Successfully formed complexes enabling electrostatic binding of ASOs to cell membranes.
• Demonstrated that the lipopeptide-oligonucleotide complexes bind to HeLa cell membranes.
• Showed that subsequent addition of dendrimers facilitates intracellular delivery of ASOs.
• Confirmed that delivered ASOs can inhibit reporter gene expression within cells.

Conclusions:

• The proposed two-step system effectively targets and delivers antisense oligonucleotides into cells.
• This approach holds promise for improving the in vivo efficiency of oligonucleotide-based therapeutics.
• Further development could lead to advanced gene silencing strategies.